Sermorelin analogue (Akela Pharma)
N/A
Report date: 2022/02/18 14:37:28
Base Information
Drug NameSermorelin analogue (Akela Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAkela Pharma
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A